What are vulval cancer and skin cancer
Vulval cancer and skin cancer are distinct conditions that can affect the vulva and the skin of the vulva, perineum, and groin. Vulval cancer arises in the external female genital tissues, most often in older women, and is frequently linked to persistent infection with high-risk human papillomavirus (HPV). Skin cancers, including melanoma and non melanoma types such as basal cell carcinoma and squamous cell carcinoma, develop in any skin and can appear on the vulva or surrounding areas due to ultraviolet exposure or other risk factors. Understanding the differences, recognizing early changes, and seeking timely evaluation are essential for effective management and better outcomes.
Types of vulval cancer
Squamous cell carcinoma
Squamous cell carcinoma is the most common type of vulval cancer. It begins in the thin, flat cells lining the vulval skin and is often associated with HPV infection. A subtype called differentiated vulvar squamous cell carcinoma may be linked to chronic inflammatory skin conditions. Early detection greatly improves treatment success.
Adenocarcinoma and other types
Adenocarcinoma starts in the glandular cells that produce mucus and may arise from Bartholin glands. Other rarer forms include melanoma, which begins in pigment producing cells, and sarcoma, which starts in connective tissues. Melanoma on the vulva can be related to UV exposure or occur without clear cause, while sarcomas are uncommon but aggressive. Knowing the specific type guides treatment planning.
- Squamous cell carcinoma: most frequent vulval cancer, often HPV driven
- Adenocarcinoma: originates from glandular tissue, sometimes Bartholin related
- Melanoma and sarcoma: rarer, pigment or connective tissue origins, distinct management
Risk factors and causes
Multiple factors can raise the likelihood of developing vulval or skin cancers on the vulva. Persistent infection with high risk HPV, particularly HPV 16, is a leading cause of squamous cell carcinoma in younger individuals. Smoking, a weakened immune system, and chronic skin conditions that cause inflammation increase risk. For melanoma, UV exposure and many moles are relevant, while fair skin and genetic factors also play a role.
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Leading cancer type | Squamous cell carcinoma | Clinical guidelines |
| Key viral risk | High risk HPV, especially HPV 16 | Epidemiological studies |
| Preventable factor | Smoking | Public health data |
| Age pattern | Higher incidence in older adults, but HPV related cases occur earlier | Population data |
| UV contribution | Primary for cutaneous melanomas, less direct for vulval squamous cancer | Dermatologic research |
Recognizing symptoms early
Common signs of vulval cancer
Persistent itching, pain, or tenderness in the vulva can be early clues. A lump, thickening, ulcer, or wart like growth that does not heal warrants evaluation. Changes in skin color or texture, unusual bleeding, or new pigmented lesions should not be ignored. Many of these signs overlap with benign conditions, so professional assessment is crucial.
Skin cancer signs on the vulva
On vulvar skin, watch for moles that change in size, shape, or color, and sores that bleed or crust. New growths or scaly patches that persist beyond a few weeks are concerning. Sun exposed areas are not the only sites; lesions can occur in covered areas too. Regular skin checks help identify changes early.
Diagnosis and staging
Diagnosis begins with a thorough clinical exam and colposcopy, often with directed biopsies of any suspicious lesions. A biopsy provides tissue for microscopic analysis to confirm cancer and determine the type. Imaging and further tests may follow to assess spread. Staging considers tumor size, depth, lymph node involvement, and distant spread, guiding treatment decisions.
Treatment approaches
Management depends on cancer type, stage, and patient health. For early vulval squamous cell carcinoma, wide local excision may be sufficient. More advanced cases might require wider surgery, lymph node assessment, or radiation. Melanoma treatment can involve targeted therapy or immunotherapy in select situations. Skin cancers on the vulva are often managed with surgical removal, with additional therapy as needed. Multidisciplinary care optimizes outcomes.
Prevention and long term follow-up
Lowering your risk
HPV vaccination reduces the risk of HPV related cancers, including some vulval cancers. Not smoking, practicing safe sun habits, and protecting skin outdoors are important for preventing skin cancers. Good genital hygiene and managing chronic inflammatory skin conditions can also help. Self awareness and prompt evaluation of new or changing lesions support early detection.
Follow-up and monitoring
After treatment, regular follow-up visits are important to monitor for recurrence and manage side effects. This may include physical exams, imaging when indicated, and skin checks. Supportive care for sexual health, urinary function, and psychosocial wellbeing completes comprehensive care. Discussing a personalized follow-up plan with your care team helps address concerns and maintain quality of life.
Questions to discuss with your clinician
- What type of cancer do I have and what does this mean for treatment?
- What are the benefits and possible side effects of each option?
- Will follow-up require scans or repeated clinic visits, and how often?
- How can HPV vaccination, sun protection, or lifestyle changes reduce future risk?
- What support services are available for sexual health, skin care, and mental health?
Key takeaways
- Vulval cancer and skin cancer can both affect the genital and perineal area but have different causes and behaviors.
- Persistent symptoms such as itching, lumps, ulcers, or changing moles should be evaluated promptly.
- Diagnosis relies on biopsy and staging, which guide tailored treatment plans.
- Prevention includes HPV vaccination, not smoking, sun protection, and regular skin awareness.
- Ongoing follow-up supports early detection of recurrence and quality of life after treatment.